Liu et al. conducted a pioneering comparative evaluation of RGD-BBN BRL radiolabeled with 18F, 64Cu, and 68Ga for dual-targeted PET imaging of breast cancer, with the aim of exploiting the overexpression of αvβ3 integrins and GRPR in tumor neovasculature and cancer cells, respectively. This evidence concerns the gene GRPR and neoplasm.